COMPANY
DMC Biotechnologies, Inc.
Funding and NIH signals
- SEC Form D raise Raised $1.41M (Form D filed Dec 30, 2025); +1 other Form D filing in the last 12 months. SEC Form D 0001231919-25-000673 (Dec 30, 2025)
Evidence (2 events)
- Dec 30, 2025 · SEC Form D 0001231919-25-000673
Name of Issuer: DMC Biotechnologies, Inc.; CIK: 1728411; Address: Boulder, CO; Submission type: D; Filing date: 2025-12-30; Industry Group: Biotechnology; Date of First Sale: 2025-12-16; Types of Securities Offered: Equity, Debt, Option/warrant, Security to be acquired, Other (Promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversion); Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 1414267; Federal exemptions: 06b - Dec 30, 2025 · SEC Form D 0001231919-25-000671
Name of Issuer: DMC Biotechnologies, Inc.; CIK: 1728411; Address: Boulder, CO; Submission type: D; Filing date: 2025-12-30; Industry Group: Biotechnology; Date of First Sale: 2025-10-31; Types of Securities Offered: Equity, Debt, Option/warrant, Security to be acquired, Other (Promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversion); Business combination transaction: false; Total Offering Amount: 1658250; Total Amount Sold: 904500; Federal exemptions: 06b
- Dec 30, 2025 · SEC Form D 0001231919-25-000673